neostigmine has been researched along with Breast Cancer in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cole, EN | 1 |
| Golder, MP | 1 |
| Groom, GV | 1 |
| Griffiths, K | 1 |
| Preece, PE | 1 |
| Hancock, BW | 1 |
2 other studies available for neostigmine and Breast Cancer
| Article | Year |
|---|---|
Plasma-hormones during anaesthesia for breast surgery.
Topics: Anesthesia, General; Breast Neoplasms; Estradiol; Female; Halothane; Humans; Neostigmine; Pancuroniu | 1976 |
Myasthenia gravis and breast carcinoma--a case report.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Middle Aged; Myasthenia G | 1976 |